SKF-83,959

From WikiMD's WELLNESSPEDIA

(Redirected from SKF-83959)

SKF-83,959 Structure


SKF-83,959 is a synthetic compound that acts as a selective dopamine receptor agonist. It is primarily used in scientific research to study the function of dopamine receptors, particularly the D1 and D5 subtypes.

Chemical Properties[edit]

SKF-83,959 has a chemical structure that allows it to selectively bind to dopamine receptors. Its chemical formula is C18H23NO2, and it has a molecular weight of 285.38 g/mol.

Pharmacology[edit]

SKF-83,959 is known for its high affinity and selectivity for the D1 and D5 dopamine receptors. These receptors are part of the dopaminergic system, which plays a crucial role in regulating motor control, cognition, and reward pathways in the brain. By activating these receptors, SKF-83,959 can mimic the effects of dopamine, a neurotransmitter that is essential for normal brain function.

Research Applications[edit]

SKF-83,959 is widely used in neuroscience research to investigate the role of dopamine receptors in various physiological and pathological processes. It has been used in studies related to Parkinson's disease, schizophrenia, and addiction. Researchers use SKF-83,959 to understand how dopamine receptor activation affects neuronal signaling and behavior.

Mechanism of Action[edit]

As a dopamine receptor agonist, SKF-83,959 binds to the D1 and D5 receptors, leading to the activation of intracellular signaling pathways. This activation results in various cellular responses, including changes in cyclic AMP levels and protein kinase A activity. These changes can influence gene expression, synaptic plasticity, and neurotransmitter release.

Side Effects and Limitations[edit]

While SKF-83,959 is a valuable tool in research, it is not used clinically due to its potential side effects and the complexity of dopamine receptor signaling. The compound can cause hyperactivity, anxiety, and other behavioral changes in animal models, which limits its use to controlled experimental settings.

See Also[edit]

References[edit]

External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.